Results from 45% of Clinical Trials are kept Secret
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the…
07/11/2016 - 2 minutes
Novartis
UPDATE: Future of CAR-T shaken by Novartis R&D Shuffle
After a promising kick off, Novartis is raising doubts about the future of its CAR-T…
27/10/2016 - 3 minutes
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company's CFO, who…
30/09/2016 - 1 minute
Debunking the Immuno-Oncology Hype: is it as good as it sounds?
CAR-T therapies have gained plenty of attention lately by promising to end cancer with a one-off…
29/09/2016 - 5 minutes
UPDATE: Novartis is Favoured to Win the Race for a New MS Drug
Novartis is poised to kick off the next generation of multiple sclerosis treatments after siponimod performs…
20/09/2016 - 2 minutes
Novartis invests in Irish Upstart tackling Chronic Inflammation
Dublin-based Inflazome has made a splashy debut by closing Series A with €15M. The company…
14/09/2016 - 2 minutes
UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study
A CAR-T program in Phase II trials (from Juno Therapeutics) was suspended by the FDA…
18/07/2016 - 5 minutes
Novartis delivers German Biotech’s 12th Antibody to Clinics
MorphoSys keeps up its impressive productivity in feeding pipelines. Its 12th antibody in its Novartis…
04/07/2016 - 2 minutes
‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease
MorphoSys confirms that its antibody (bimagrumab) failed to meet the primary endpoint of a phase…
27/04/2016 - 2 minutes
Cancer: World Best Ever CAR-T Results have Just been Disclosed
These are the best results yet for CAR-T, this time from a research group led by…
17/02/2016 - 3 minutes
The European Union Finances the Future of CAR-T Manufacturing
CAR-T is the way forward in Cancer therapeutics, which is one of the leading causes…
08/02/2016 - 3 minutes
World CAR-T Leader Starts New Program with a UK Biotech
Pretty impressive CAR-T news coming from across the Channel... Oxford BioMedica just launched a second…
01/02/2016 - 2 minutes
